Abstract
The frequency of psychopathological symptoms in patients with Parkinson’s disease (PD) is often underestimated because of the lack of comprehensive evaluation tools. A total of 486 consecutive non-demented PD patients completed the Symptom Checklist 90 Revised (SCL-90R) self-reported questionnaire, a validated tool for the assessment of psychopathological symptoms on nine dimensions. Somatization, depression, anxiety and obsessive–compulsive behaviors were reported by nearly half of the PD patients. They were more likely to occur in females. Disease-related factors such as duration, severity and daily dosages, but not type of dopaminergic medications, were associated with the occurrence of these symptoms. Psychopathological features are frequent in PD and their occurrence is underlined by disease-related factors.
Similar content being viewed by others
References
Lauterbach EC (2004) The neuropsychiatry of Parkinson’s disease and related disorders. Psychiatr Clin North Am 27(4):801–825
Nuti A, Ceravolo R, Piccinni A, Dell’Agnello G, Bellini G, Gambaccini G et al (2004) Psychiatric comorbidity in a population of Parkinson’s disease patients. Eur J Neurol 11(5):315–320
Cummings JL, Masterman DL (1999) Depression in patients with Parkinson’s disease. J Geriatr Psychiatry 14:711–718
Richard IH, Schiffer RB, Kurlan R (1996) Anxiety and Parkinson’s disease. J Neuropsychiatry Clin Neurosci 8(4):383–392
Maia AF, Pinto AS, Barbosa ER, Menezes PR, Miguel EC (2003) Obsessive–compulsive symptoms, obsessive–compulsive disorder, and related disorders in Parkinson’s disease. J Neuropsychiatry Clin Neurosci 15(3):371–374
Alegret M, Junque C, Valldeoriola F, Vendrell P, Marti MJ, Tolosa E (2001) Obsessive–compulsive symptoms in Parkinson’s disease. J Neurol Neurosurg Psychiatry 70(3):394–396
Muller N, Putz A, Kathmann N, Lehle R, Gunther W, Straube A (1997) Characteristics of obsessive–compulsive symptoms in Tourette’s syndrome, obsessive–compulsive disorder, and Parkinson’s disease. Psychiatry Res 70(2):105–114
Voon V, Fox SH (2007) Medication-related impulse control and repetitive behaviours in Parkinson disease. Arch Neurol 64(8):1089–1096
Potenza MN, Voon V, Weintraub D (2007) Drug insight: impulse control disorders and dopamine therapies in Parkinson’s disease. Nat Clin Pract Neurol 3(12):664–672
Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A (2008) The relationship between impulsivity and impulse control disorders in Parkinson’s disease. Mov Disord 23(3):411–415
Aarsland D, Brønnick K, Ehrt U, De Deyn PP, Tekin S, Emre M et al (2007) Neuropsychiatric symptoms in patients with Parkinson’s disease and dementia: frequency, profile and associated caregiver stress. J Neurol Neurosurg Psychiatry 78(1):36–42
Koh KB, Kim DK, Kim SY, Park JK, Han M (2008) The relation between anger management style, mood and somatic symptoms in anxiety disorders and somatoform disorders. Psychiatry Res 160(3):372–379
Martinotti G, Mandelli L, Di Nicola M, Serretti A, Fossati A, Borroni S, Cloninger CR, Janiri L (2008) Psychometric characteristic of the Italian version of the temperament and character inventory—revised, personality, psychopathology, and attachment styles. Compr Psychiatry 49(5):514–522
Goldwurm S, Zini M, Di Fonzo A, De Gaspari D, Siri C, Simons EJ et al (2006) LRRK2 G2019S mutation and Parkinson’s disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample. Parkinsonism Relat Disord 12(7):410–419
Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: a clinicopathologic study. Neurology 42:1142–1146
Grosset KA, Grosset DG (2006) Proposed dose equivalence for rapid switching between dopamine agonists in Parkinson’s disease. Clin Ther 28:1063–1064
Derogatis LR (1977) SCL-90-R: administration, scoring and procedures manual. Clinical Psychometrics Research, Baltimore
Pedersen G, Karterud S (2004) Is SCL-90R helpful for the clinician in assessing DSM-IV symptom disorders? Acta Psychiatr Scand 110(3):215–224
Aben I, Denollet J, Lousberg R, Verhey F, Wojciechowski F, Honig A (2002) Personality and vulnerability to depression in stroke patients: a 1-year prospective follow-up study. Stroke 33(10):2391–2395
Davies FG, Manchanda R, Schaefer B, Blume WT, McLachlan RS (1992) Sexual abuse and psychiatric symptoms in an epileptic population. Seizure 1(4):263–267
Offenbaecher M, Glatzeder K, Ackenheil M (1998) Self-reported depression, familial history of depression and fibromyalgia (FM), and psychological distress in patients with FM. Z Rheumatol 57(Suppl 2):94–96
Erbil P, Razavi D, Farvacques C, Bilge N, Paesmans M, Van Houtte P (1996) Cancer patients’ psychological adjustment and perception of illness: cultural differences between Belgium and Turkey. Support Care Cancer 4(6):455–461
Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H et al (2004) ESEMeD/MHEDEA 2000. Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project. Acta Psychiatrica Scandinavica Suppl 420:21–27
Koerts J, Leenders KL, Koning M, Portman AT, van Beilen M (2007) Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson’s disease. Eur J Neurosci 25(10):3132–3136
Koerts J, Leenders KL, Koning M, Bouma A, van Beilen M (2008) The assessment of depression in Parkinson’s disease. Eur J Neurol 15(5):487–492 Epub 2008 Mar 18
Stein DJ, Muller J (2008) Cognitive–affective neuroscience of somatization disorder and functional somatic syndromes: reconceptualizing the triad of depression–anxiety–somatic symptoms. CNS Spectr 13(5):379–384
Owen AM, James M, Leigh PN, Summers BA, Marsden CD, Quinn NP et al (1997) Fronto-striatal cognitive deficits at different stages of Parkinson’s disease. Brain 115:1727–1751
Dirnberger G, Frith CD, Jahanshahi M (2005) Executive dysfunction in Parkinson’s disease is associated with altered pallidal-frontal processing. Neuroimage 25(2):588–599
Eidelberg D, Moeller JR, Antonini A, Kazumata K, Dhawan V, Budman C et al (1997) The metabolic anatomy of Tourette’s syndrome. Neurology 48:927–934
Wolters ECh (2006) PD-related psychosis: pathophysiology with therapeutical strategies. In: Parvez H, Riederer P (eds) Oxidative stress and neuroprotection. J Neural Transm Suppl. Springer, Wien New York, vol 71, pp 31–37
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Siri, C., Cilia, R., De Gaspari, D. et al. Psychiatric symptoms in Parkinson’s disease assessed with the SCL-90R self-reported questionnaire. Neurol Sci 31, 35–40 (2010). https://doi.org/10.1007/s10072-009-0165-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-009-0165-0